Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla

BSE1402.102.75 (+0.2 %)

PREV CLOSE ( ) 1399.35

OPEN PRICE ( ) 1409.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3377

TODAY'S LOW / HIGH ( )1400.90 1409.95

52 WK LOW / HIGH ( )911.8 1519

NSE1403.003.95 (+0.28 %)

PREV CLOSE( ) 1399.05

OPEN PRICE ( ) 1403.90

BID PRICE (QTY) 1403.00 (125)

OFFER PRICE (QTY) 1404.00 (102)

VOLUME 29618

TODAY'S LOW / HIGH( ) 1400.35 1407.00

52 WK LOW / HIGH ( )911.55 1519

Chairman	Y K Hamied
Managing Director	Umang Vohra
Company Secretary	Rajendra Chopra
Vice Chairman	MK Hamied
Non Executive Director	Samina Hamied
Non Executive Independent Director	Adil Zainulbhai Ashok Sinha Punita Lal PR Ramesh Robert Stewart Mandar Purushottam Vaidya
Non Independent & Non Executive Director	S Radhakrishnan

Incorporation Year : 17-08 1935

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel Mumbai,
Maharashtra-400013 .

Phone : 022-24826000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,Luxembourg, MCX